Sharon Alroy-Preis Selected Research

A-factor (Streptomyces)

1/2023	Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel (ICoFS): a prospective cohort study.
1/2022	Protection following BNT162b2 booster in adolescents substantially exceeds that of a fresh 2-dose vaccine.
1/2022	Protection by a Fourth Dose of BNT162b2 against Omicron in Israel.
12/2021	Protection against Covid-19 by BNT162b2 Booster across Age Groups.
10/2021	Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sharon Alroy-Preis Research Topics

Disease

15	COVID-19 05/2024 - 01/2021
14	Infections 01/2023 - 01/2021
3	Myocarditis (Carditis) 10/2022 - 12/2021
2	Poliomyelitis (Polio) 05/2023 - 01/2022
1	Reinfection 01/2022
1	Breakthrough Infections 01/2022
1	Asymptomatic Infections 01/2021
1	Hepatitis C 07/2014

Drug/Important Bio-Agent (IBA)

18	BNT162 VaccineIBA 05/2024 - 01/2021
16	VaccinesIBA 05/2023 - 01/2021
5	Messenger RNA (mRNA)IBA 05/2024 - 01/2021
5	A-factor (Streptomyces)IBA 01/2023 - 10/2021
2	AntibodiesIBA 01/2023 - 01/2022
1	Immunoglobulin G (IgG)IBA 01/2023
1	COVID-19 VaccinesIBA 01/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2022
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2022
1	mRNA VaccinesIBA 12/2021
1	Neutralizing AntibodiesIBA 12/2021
1	EnzymesIBA 07/2014